Literature DB >> 6887900

Variability of pharmacokinetic parameters for contraceptive steroids.

K Fotherby.   

Abstract

Studies of the pharmacokinetics of three contraceptive steroids, ethynyloestradiol, norethisterone and norethisterone oenanthate, in large groups of women are reviewed. Extremely wide variations were observed between women in the various calculated pharmacokinetic parameters. Studies carried out in small groups of subjects may give misleading results. It is difficult to ascribe any meaning and interpretation to most of the derived values but they do provide a means of comparing aspects of the metabolism of the various steroids. It is difficult to relate the pharmacokinetic values to the various biological actions of the steroids. However, the wide variations between subjects in the pharmacokinetic parameters must indicate equally wide variations in the biological activity of the steroids. Subjects in whom the bio-availability is low or where the rate of metabolism is rapid might be expected to respond differently, both in terms of efficacy and side-effects, from subjects with high values for bio-availability and a slow metabolism.

Entities:  

Keywords:  Biology; Contraception; Contraceptive Agents, Estrogen; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Agents--pharmacodynamics; Contraceptive Methods; Ethinyl Estradiol--pharmacodynamics; Family Planning; Injectables; Metabolic Effects; Norethindrone Enanthate--pharmacodynamics; Norethindrone--pharmacodynamics; Physiology; Reproductive Control Agents; Steroid Metabolic Effects

Mesh:

Substances:

Year:  1983        PMID: 6887900     DOI: 10.1016/0022-4731(83)90017-1

Source DB:  PubMed          Journal:  J Steroid Biochem        ISSN: 0022-4731            Impact factor:   4.292


  9 in total

Review 1.  Pharmacokinetic drug interactions involving 17alpha-ethinylestradiol: a new look at an old drug.

Authors:  Hongjian Zhang; Donghui Cui; Bonnie Wang; Yong-Hae Han; Praveen Balimane; Zheng Yang; Michael Sinz; A David Rodrigues
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

2.  Relationship between patient characteristics and serum etonogestrel concentrations in contraceptive implant users.

Authors:  Aaron Lazorwitz; Christina L Aquilante; Jeanelle Sheeder; Maryam Guiahi; Stephanie Teal
Journal:  Contraception       Date:  2019-04-10       Impact factor: 3.375

3.  Influence of Genetic Variants on Steady-State Etonogestrel Concentrations Among Contraceptive Implant Users.

Authors:  Aaron Lazorwitz; Christina L Aquilante; Kris Oreschak; Jeanelle Sheeder; Maryam Guiahi; Stephanie Teal
Journal:  Obstet Gynecol       Date:  2019-04       Impact factor: 7.661

4.  Estimating systemic exposure to ethinyl estradiol from an oral contraceptive.

Authors:  Carolyn L Westhoff; Malcolm C Pike; Rosalind Tang; Marianne N DiNapoli; Monica Sull; Serge Cremers
Journal:  Am J Obstet Gynecol       Date:  2014-12-12       Impact factor: 8.661

Review 5.  Levonorgestrel. Clinical pharmacokinetics.

Authors:  K Fotherby
Journal:  Clin Pharmacokinet       Date:  1995-03       Impact factor: 6.447

Review 6.  Individual variation in first-pass metabolism.

Authors:  Y K Tam
Journal:  Clin Pharmacokinet       Date:  1993-10       Impact factor: 6.447

7.  Relationship Between Etonogestrel Concentrations and Bleeding Patterns in Contraceptive Implant Users.

Authors:  Aaron Lazorwitz; Christina L Aquilante; Eva Dindinger; Margaret Harrison; Jeanelle Sheeder; Stephanie Teal
Journal:  Obstet Gynecol       Date:  2019-10       Impact factor: 7.661

8.  The injectable-only contraceptive medroxyprogesterone acetate, unlike norethisterone acetate and progesterone, regulates inflammatory genes in endocervical cells via the glucocorticoid receptor.

Authors:  Yashini Govender; Chanel Avenant; Nicolette J D Verhoog; Roslyn M Ray; Nicholas J Grantham; Donita Africander; Janet P Hapgood
Journal:  PLoS One       Date:  2014-05-19       Impact factor: 3.240

Review 9.  Drug interactions between hormonal contraceptives and antiretrovirals.

Authors:  Kavita Nanda; Gretchen S Stuart; Jennifer Robinson; Andrew L Gray; Naomi K Tepper; Mary E Gaffield
Journal:  AIDS       Date:  2017-04-24       Impact factor: 4.177

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.